Moneycontrol PRO
you are here: HomeNewsNtagi
ntagi
Jump to
9 Results Found
  • COVID-19 | Vaccination of 12-14 age group likely to start from March Jan 17, 2022 12:56 PM IST

    COVID-19 | Vaccination of 12-14 age group likely to start from March

    The government is also looking to give all the 7.4 crore adolescents in the 15-17 age bracket their first dose by January-end, so that their second dose is done by the end of February, NTAGI chief Dr NK Arora has said

  • No need for boosters, 2 jabs of vaccine enough for human body to fight Covid-19: NTAGI member Dec 22, 2021 09:03 PM IST

    No need for boosters, 2 jabs of vaccine enough for human body to fight Covid-19: NTAGI member

    Dr Jayaprakash Muliyil, who is a professor at CMC in Vellore, explained that vaccines programme our body to recognise antigens so that when an infection occurs, the immune system wakes up and starts fighting against it.

  • No need to vaccinate children against Covid right now, Centre informed about decision: NTAGI member Dec 21, 2021 03:01 PM IST

    No need to vaccinate children against Covid right now, Centre informed about decision: NTAGI member

    The data driving the decision to not vaccinate children on an urgent basis shows no significant mortality among children due to Covid-19.

  • No recommendation from NTAGI yet on inoculating children: V K Paul Dec 10, 2021 07:45 PM IST

    No recommendation from NTAGI yet on inoculating children: V K Paul

    On a question on Covid booster doses for adults, VK Paul said, "We are keeping an eye on global scientific studies in this regard.”

  • NTAGI to consider administering 'additional' dose of COVID-19 vaccine to immunocompromised people Dec 05, 2021 08:09 PM IST

    NTAGI to consider administering 'additional' dose of COVID-19 vaccine to immunocompromised people

    .A booster dose is given to an individual after a predefined period when the immune response due to primary vaccination is presumed to have declined, while additional dose is given to immunocompromised and immunosuppressed individuals when primary schedule of vaccination does not provide adequate protection from the infection and disease.

  • No scientific evidence to support need for booster vaccine dose against Covid: ICMR chief Nov 22, 2021 04:16 PM IST

    No scientific evidence to support need for booster vaccine dose against Covid: ICMR chief

    According to sources, the booster dose issue is likely to be discussed in the next meeting of the National Technical Advisory Group on Immunisation in India (NTAGI).

  • Zydus Cadila proposes Rs 1900 for three-dose COVID vaccine; Govt negotiating to bring it down Oct 03, 2021 06:31 PM IST

    Zydus Cadila proposes Rs 1900 for three-dose COVID vaccine; Govt negotiating to bring it down

    .

  • COVID-19 Vaccine | Centre considering reducing gap for Covishield jabs for 45+ ages Aug 05, 2021 09:21 AM IST

    COVID-19 Vaccine | Centre considering reducing gap for Covishield jabs for 45+ ages

    "In two to four weeks we may decide on reducing dosage interval of Covishield, especially for those above 45 years and elderly based on final scientific evidence,” NTAGI Chairperson NK Arora said

  • COVID-19 vaccine | Decision to increase Covishield interval taken on scientific data: NTAGI chief Jun 16, 2021 10:38 AM IST

    COVID-19 vaccine | Decision to increase Covishield interval taken on scientific data: NTAGI chief

    NTAGI Chair NK Arora added that “there was no dissenting voice among the NTAGI members” in regards to the decision.

Sections
ISO 27001 - BSI Assurance Mark